Skip to main content

Value of ultrasound fusion imaging in detecting vascular cerebral white matter pathology



Transcranial sonography is beside magnetic resonance imaging (MRI) and computed tomography, a well-established imaging method for evaluation of brain parenchyma and already implicated in various neurological disorders as bed-side investigation possibility in clinical routine. The aim of this study was the qualitative assessment detecting vascular white matter hyperintensities (WMHs), with ultrasound fusion-imaging technique (UFI) and to find the optimal location for their visualization in accordance to the grade of WMHs and to possibly providing a standardized protocol for clinical use.


29 patients with WMHs of variable degree quantified according to Fazekas grading scale (n = 13 I; n = 9 II; n = 7 III) and 11 subjects with normal findings on MRI were identified for further analysis. Ultrasound images were analyzed to a standardized protocol and predefined anatomical landmarks. UFI could visualize the MRI-verified WMHs in 147 of 161 localizations (91%). The overall ultrasound detection rate of WMHs increased with higher degree of WMHs burden (I:85%, II:94%, III:97%). The highest sensitivity was achieved at the contralateral central part (CPc) (97%) of the lateral ventricle. The inter-rater analysis between 2 independent raters, who were blinded to the patient’s diagnosis and assessed only the B-mode ultrasound images, indicated an 86% agreement with an overall moderate strength of agreement (κ: 0.489, p < 0.0005) for all localizations. The highest accordance within raters was shown at the CPc; 92% (κ: 0.645, p < 0.0005).


This explorative study describes prospectively the ultrasound detection of periventricular vascular WMHs based on MRI lesions using UFI. Transcranial ultrasound (TCS) could serve as an additional screening opportunity for the detection of incidental WMLs during routine TCS investigations to initiate early vascular risk factor modification in primary prevention.


Cerebral small vessel disease (CSVD) is a common neurological disease and comprises clinical, histopathological and imaging features. It causes about 20% of all strokes worldwide and is related to up to 45% of dementias, late-life depression, behavioral and gait disturbances [1, 2]. The diagnosis of CSVD relies on imaging findings and include white matter hyperintensities (WMHs), small subcortical infarcts, cerebral microbleeds, lacunar infarcts and brain atrophy. WMHs are variable in size and are mainly located periventricular, the deep and subcortical white matter. Pathophysiologically, WMHs have been linked to different degrees of demyelination, axon loss, gliosis, perivascular tissue changes, thickened vessel walls, venous collagenosis or perivascular edema due to intermittent disruption of the blood–brain barrier [3,4,5].

Less is known about the causal association between CSVD and its clinical sequelae [6]. For instance, vascular cognitive impairment (VCI) is the second cause of cognitive decline which results from different etiologies, like large or strategic stroke, multi-infarct strokes, border-zone infarcts or cerebral small vessel disease. The cause of microstructural changes in VCI are not completely clear. Evidence suggests oxidative stress, neuroinflammation, endothelial dysfunction, neurotransmitter imbalance. There is growing evidence exploring VCI, especially in defining strategies for diagnosis in very early stages or to find specific markers for patients at risk to further develop strategies for accurate diagnosis and preventive patient-tailored therapeutical options [7].

The standard imaging techniques to visualize white matter lesions (WMLs) in CSVD are brain magnetic resonance imaging (MRI) and computed tomography (CT). The Fazekas grading (Grade I–III) scale is the most commonly used classification system to quantify vascular WMLs on brain MRI or CT radiologically [8].

Another, but not routinely applied method of brain parenchyma imaging is ultrasound (US). Nowadays, high-end ultrasound systems achieve high image resolution. Transcranial sonography of brain parenchyma is well established in diagnosing and monitoring degenerative brain disorders [9, 10]. Particularly, transcranial ultrasound assessment of the substantia nigra in neurodegenerative disorders can help to differentiate between Parkinson disease and essential tremor with a sensitivity of  > 90% and a specificity of  > 89% [11]. The usage of TCS also in emergency department setting is a promising application, since it might be able to distinguish, e.g., unclear neurological movement disorders with acute onset in patients presenting at ED [12].

Further with TCS it is feasible to control the position of deep brain stimulation electrodes postoperatively and it is a reliable method for bed-side monitoring of midline shift in stroke and intracranial hemorrhage [13,14,15].

Ultrasound fusion imaging (UFI) enables the combination of real-time benefits resulting from US and the anatomical clarity of CT/MR images which helps understanding the sometimes difficult interpretation of transcranial US images and thus allows real-time navigation, exact assessment and correlation of specific structures. However, it is highly operator and experience-dependent procedure [16]. In CSVD this application has not been investigated until now. US is noninvasive, non-radiative, easily repeatable at bedside and widely available.

The aim of this study was that with ultrasound fusion imaging technique based on MR images, it is possible to detect vascular WMLs due to their alteration of echogenicity of brain parenchyma with TCS and to examine the optimal localizations for their detection.



Thirty-six consecutively admitted patients with vascular WMLs on MRI and 12 consecutively admitted subjects with normal MRI brain findings as control group were screened for the study. Additional inclusion criteria were: age > 18 years, suitable temporal bone window and absent contraindication for MRI and UFI. Patients with any acute brain lesions, known neurodegenerative or neuroinflammatory diseases were not included.

We performed this pilot study at the Department of Neurology (location temporarily anonymized). Demographic data, relevant cardiovascular comorbidities and medications were documented (Table 1).

Table 1 Demographic and comorbidity characteristics of 40 subjects

Ultrasound fusion imaging

All ultrasound investigations were performed by one experienced investigator (temporarily anonymized) with an ESAOTE Mylab Twice Virtual Navigator® ultrasound system (Genoa, Italy) The ultrasound system was equipped with the Virtual Navigation option (Med-Com GmbH, Darmstadt, Germany).

Brain tissue was visualized bilaterally from transtemporal approach using a phased-array transducer (Esaote, PA240, Genoa, Italy) with an operating frequency of 4.0–1.0 MHz in B-Mode followed by fusion of imported MR images in DICOM format. MR images were performed with 1.5 Tesla scanner with axial slices, slice thickness 5.00 mm and 10% gap (GE Medical System Signa HDxt, 1.5 T, Chicago, USA). Only subjects with a suitable transtemporal bone window were included in our study. This was defined as clear visualization of contralateral skull bone and midbrain structures in axial midbrain imaging plane and lateral ventricles as well in cella media plane [17].

The US registration procedure followed a protocol already published in 2015 [18]. For fusion registration procedure TOF sequences and for online analysis during US session FLAIR sequences were used. Grading of WMLs on MRI was carried out by an experienced neuroradiologist (temporarily anonymized) using the Fazekas rating scale for cerebral WML; Fazekas 0 = None or a single punctate WMH lesion, Fazekas I (mild): multiple punctate lesions, Fazekas II (moderate): beginning confluence of lesions (bridging), Fazekas III (severe): large confluent lesions [8].

During clinical US examination, US and MR images were fused. As anatomical landmark for fusion, we determined a minimum of insonation-length of 1 cm of the ipsilateral middle cerebral artery (MCA) in color Doppler mode in axial scanning approach (Fig. 1). After US visualization of the MCA, US images were fused with the corresponding MRI images (TOF) and the position of the images were corrected to match accurately if necessary (Fig. 1).

Fig. 1
figure 1

Fusion procedure of ultrasound (US) and MR images. The ipsilateral middle cerebral artery (MCA) is determined as anatomical landmark. After US visualization of the ipsilateral MCA in color-coded duplex ultrasonography (TCCS), axial scanning approach, US images are fused with the corresponding MR images (TOF-sequence) and corrected, if necessary, to match perfectly (a–c). During UFI investigation MR FLAIR images are used for online examination (df). a–c: Left: TCCS MCA ipsilateral. Middle: MR TOF angiography. Right: Fused images. d–f: Left: TCS in B-Mode. Middle: cerebral MR FLAIR image, axial plane. Right: fused images US and MRI. White matter lesions (WMLs) II, Anterior horn contralateral. White arrows indicate the WMLs

According to the main locations of periventricular and deep white matter vascular WMLs, we predefined three anatomical regions of the lateral ventricle for investigation: (a) frontal horn area (FH), dorsal horn area (DH) and the central part area including the deep white matter (CP).

All localizations were examined ipsi- and contra-laterally from each side.

The cella media plane displayed the optimal insonation angle for visualization of the central part of the lateral ventricle bilaterally. The cella media plane was reached by tilting the probe further upward from the midbrain plane axially. Investigation of the frontal, the dorsal horns and the deep white matter was performed in thalamic plane.

Image analysis

The TCS images in B-mode and all fused images firstly were analyzed from principal investigator online during UFI session. Observations were documented and the images saved in DICOM format. After the first analysis was done, two independent experienced ultra-sonographers (temporarily anonymized), who had been standardized instructed with representative US patterns and were blinded to patients’ diagnosis, evaluated solely B-mode US images for inter-rater analysis. To reduce/exclude the analysis bias the frozen US images selected for further analysis were strictly in accordance with clear and reproducible anatomical landmarks visualized with ultrasound, independent of WMLs load seen on MRI.

Statistical analysis

The statistical analysis was performed using the SSPS statistical software system (IBM SPSS Statistics for Mac, Version, IBM Corp. Armonk, NY, 2019). Patients’ demographic and clinical characteristics are given as means ± standard deviations (SD), as medians and ranges or as percentages. For between-group comparisons the Student´s t-test was used, and for categorical variables the Chi-squared test. Fleiss` kappa analysis was performed to assess inter-rater agreement for three raters. Kappa (κ) values of < 0 were assumed as poor; 0.01–0.20 as slight; 0.21–0.40 as fair; 0.41–0.60 as moderate; 0.61–0.80 as substantial and 0.81–1.00 as almost perfect agreement. Converted into p-values significance was assumed at p < 0.05. Sensitivity is given as an average value in percent [19].

Standard protocol approval and patient consent

All participants gave written informed consent. The study was approved by the local ethics committee (temporarily anonymized).


From 48 subjects screened for the study, 8 cases (7 in WMLs group, 1 in control group) had missing temporal bone windows and were excluded from further analysis. 29 patients in the WML group and 11 subjects from the control group, were considered for further US investigation and analysis. 29 patients showed vascular WMLs of variable degree quantified according to Fazekas grading scale (n = 13 I; n = 9 II; n = 7 III). Demographic and clinical data are depicted in Table 1.

Only images with reproducible clear anatomical landmarks per localization were included, therefore 233 localizations (161 with WMLs, 72 with normal MRI findings) were identified for further evaluation. In subjects with sufficient transtemporal bone window both ipsi- and contra-lateral localizations were analyzed.

TCS-MRI fusion imaging technique could visualize the MRI-verified WMLs in 147 of 161 localizations (sensitivity: 91%). The overall US detection rate of WMLs increased with higher degree of WML burden (I: 85%, II: 94%, III: 97%). The highest sensitivity was achieved at the contralateral central part (CPc) (97%), the contralateral dorsal horn (DHc) (96%) and the contralateral frontal horn (FHc) (95%). From the control group with normal MRI findings 72 localizations were identified for analysis. 54 localizations (specificity: 75%) were ultrasonographically identified consistently as normal.

The inter-rater analysis from 2 independent raters indicated an 86% agreement with an overall moderate strength of agreement (κ: 0.489, p < 0.0005) for all localizations. The highest accordance within raters was shown at the CPc; 92% (κ: 0. 645, p < 0.0005) and at the ipsilateral frontal horn (FHi); 90% (κ: 0. 644, p < 0.0005), both defined as substantial agreement; whereas, fair agreement was observed at the FHc, the CPi and the DHc. The detailed distribution of localizations and subjects is shown in Table 2. Quantitative analysis of degree of WMLs was not conducted based on US images.

Table 2 Detailed distribution of evaluated images per localization


This study shows that transcranial B-mode sonography seems to be able qualitatively detect vascular WMLs based on MR images with a sensitivity of 91%. The combination of MR images with US images during US examination increases the detection rate of periventricular WMHs on US images in B-Mode since the MR images help to find the lesions with US. The highest sensitivity of WMHs ultrasound detection was shown at the contralateral central part and the contralateral frontal horn of the lateral ventricle and increases with WMH burden.

TCS is a well-established imaging technique in neurology to investigate brain parenchyma in various brain disorders and can complement information from other neuroimaging modalities [20, 21]. Brain CT or MR images superimposed to TCS insonation image show the almost perfect correspondence of anatomic structures intra- and extra-cranially and can aid the ultra-sonographer during the US session. Generally, the advantages of merging two imaging modalities for investigations or surgeries are common in other specialties (e.g., urology, neurosurgery) [22,23,24].

MRI-verified WMHs in periventricular location correspond to sonographic reproducible hyperechogenic structures, like double or blurred lines or hyperechogenic lesions surrounding the wall of lateral ventricles. In case of confluent deep white matter lesions, the brain parenchyma appeared more inhomogeneous in echogenicity with ultrasound in comparison to normal brain parenchyma, where the US image showed a more homogeneous echogenic pattern (Fig. 2). Maybe these change in echogenicity are more often seen on anatomical borderlines between brain parenchyma and lateral ventricle wall, and are more evident in case of WMH pathology. Especially in the control group sometimes we observed small hyperechogenic signals, like white caps, at frontal horns directly on the border of the ventricle wall and brain parenchyma, but thought as artifacts due to their inconstancy in appearance. This observation could be a reason for the low specificity.

Fig. 2
figure 2

US visualization of WMLs based on MRI. The brain lesions seen on MR images correspond on ultrasound (US) images to hyperechogenic signals, double or blurred lines or as inhomogeneous hyperechogenic signal surrounding the wall of the central part, the frontal or dorsal horns of the lateral ventricles. Left: cerebral MR FLAIR image, axial plane. Right: transcranial sonography in B-Mode. a, b: WMLs I, white arrows indicate WML at the anterior horn ipsilateral. c, d WMLs II, white arrows indicate WML at the dorsal horn contralateral. e, f WMLs III, white arrows indicate WML in the deep white matter surrounding the central part contralateral

Several US studies indicated that ionic deposits like iron, copper or manganese lead to hyper-echogenicity in different brain structures in neurodegenerative disorders [25,26,27,28]. Additionally, calcification can lead to an increased echogenicity. Petersen et al. recently reported a decrease of structural connectivity in patients with higher CSVD burden in which the frontal brain regions were prominently affected and hypothesized a disruptive effect on white matter fiber tracts [29]. Increased interstitial water content results in signal changes on MRI, typically on FLAIR and T2WI sequences [30]. Histologically in extensive WMLs decreased density of glial cells and vacuolization are the leading pathological findings, whereas subtle WMLs show a highly variable histopathology [31]. Conceivably, the loss of structural integrity, increased perivascular water content and damaged white matter fibers due to CSVD leading to a change of echogenicity with US. Further, transcranial Doppler sonography (TCD) data pointed out changes in the cerebral perfusion and vascular resistance, linked to microcirculation pathology and small vessel und capillary damage, in patients with VCI without evident dementia significantly associated with WMLs [32]. These changes might display the neurosonological correlates of microcirculatory pathology in patients with WMLs additionally to the TCS imaging findings. Contrary, some hemodynamic studies observed changes in TCD parameters in asymptomatic patients with Fabry´s disease, without any additional vascular risk factors or evident brain MRI lesions [33]. These findings have been considered to use TCD parameters as a screening method for patients at risk for both acute stroke and chronic cerebrovascular disease as well.

In newborn infants ultrasound examination of the brain is a common and reliable method. Correlation of US with MRI images in the detection of WMLs in newborns showed low reliability in subtle WMLs, while the visualization rate of severe and diffuse WMLs in the frontal and periventricular region with cranial US correlates well to hyperechogenic lesions identified on MRI [34,35,36]. These results are consistent with our observations. The highest sensitivity for WMLs US detection and inter-rater agreement was found in the frontal and central periventricular brain areas. At the posterior regions hyperintense artifacts were seen more often, mostly raising from the choroid plexus. UFI was a helpful tool to distinguish hyperechogenic artifacts from WMLs. Furthermore, the number of localizations at the CPi and the DHi is low, due to insufficient insonation angle and unreproducible depiction possibility of anatomical landmarks. Spotty lesions in the deep white matter were not visualizable with UFI as well.

The automatized quantification of echogenicity values from TCS-MRI fusion images in neurodegenerative disorders or of the insula demonstrates a high reliability using B-Mode Assist System [37, 38]. We evaluated US images without any automatized software, but constantly with the same presets. Further automatized imaging analysis should be tested to evaluate if the severity of WMLs burden could be graded with TCS.

This study has some limitations. US is known to be examiner dependent. Missing transtemporal bone window makes US examination impossible (in our study: WMLs group: 19%, control group: 8%). To apply fusion technique during TCS examination correctly, it is crucial to guarantee an almost perfect match to pre-acquired MRI images reproducibly. Therefore, standardized investigation protocols should be used. Due to anatomical variants the dorsal horn ipsi- and contra-laterally was not visualizable constantly in every patient. Also, the choroid plexus causes a hyperechogenic signal at the dorsal horn region, which sometimes makes it harder to visualize WLMs. In fact, the number in these localizations for evaluation is low. Further, the sample size is relatively low, because during the observation time of 3 months, there were no more patients who matched the inclusion criteria for this study.

Moreover, the question arises whether sonographically characteristic hints or patterns can be detected and defined to distinguish between vascular, inflammatory or degenerative white matter lesions with US, which sometimes is not fully differentiable on MR images alone. At this timepoint it is not clear if UFI/TCS is able to differentiate between vascular, demyelinating, metabolic cerebral WMLs. Further studies are necessary and planned to answer this question. The experimental insonation of white matter lesion in multiple sclerosis, performed in a few patients during study time, showed a different appearance on US images in comparison to vascular lesion. So, the hypothesis arises that this method maybe has the potential to differentiate these lesions etiologically.


We described the US detection of periventricular vascular white matter hyperintensities in adults based on MRI lesions using B-Mode ultrasound fusion imaging technique; a further blinded study is planned. MRI is the valid gold standard imaging method in precise detection of WMLs. US could serve as an additional tool during routine TCS investigations as a screening method for CSVD. Incidental WLMs detection by routine TCS could then lead to early vascular risk evaluation in primary prevention.

Availability of data and materials

The dataset used and analyzed during the current study are available from the first author and the corresponding author on reasonable request.



Central part (contralateral) (ipsilateral)


Cerebral small vessel disease


Dorsal horn (contralateral) (ipsilateral)


Frontal horn (contralateral) (ipsilateral)


Inter-rater analysis




Middle cerebral artery


Standard deviations


Transcranial Doppler sonography


Transcranial sonography


Ultrasound fusion imaging




Vascular cognitive impairment


White matter hyperintensities


White matter lesions


  1. Ryoo S, Park JH, Kim SJ, Kim GM, Chung CS, Lee KH, Kim JS, Bang OY (2012) Branch occlusive disease: clinical and magnetic resonance angiography findings. Neurology 78(12):888–896

    Article  CAS  Google Scholar 

  2. Shi Y, Wardlaw JM (2016) Update on cerebral small vessel disease: a dynamic whole-brain disease. Stroke Vasc Neurol 1:83–92

    Article  Google Scholar 

  3. Braffman BH, Zimmerman RA, Trojanowski JQ et al (1988) Brain MR: pathologic correlation with gross and histopathology. 1. Lacunar infarction and Virchow-Robin spaces. AJR Am J Roentgenol 151:551–558

    Article  CAS  Google Scholar 

  4. Li Q, Yang Y, Reis C et al (2018) Cerebral small vessel disease. Cell Transpl 27:1711–1722

    Article  Google Scholar 

  5. Pantoni L (2010) Cerebral small vessel disease- from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 9:689–701

    Article  Google Scholar 

  6. Ter Telgte A, Van Leijsen EMC, Wiegertjes K et al (2018) Cerebral small vessel disease: from a focal to a global perspective. Nat Rev Neurol 14:387–398

    Article  Google Scholar 

  7. Vinciguerra L, Lanza G, Puglisi V et al (2020) Update on the Neurobiology of Vascular Cognitive Impairment: From Lab to Clinic. Int J Mol Sci 21(8):2977

    Article  CAS  Google Scholar 

  8. Fazekas F, Barkhof F, Wahlund LO, Pantoni L, Erkinjuntti T, Scheltens P, Schmidt R (2002) CT and MRI rating of White Matter Lesions. Cerebrovasc Dis 13(2):31–36

    Article  Google Scholar 

  9. Berg D, Godau J, Walter U (2008) Transcranial sonography in movement disorders. Lancet Neurol 7(11):1044–1055

    Article  Google Scholar 

  10. Walter U, Behnke S, Eyding J et al (2007) Transcranial brain parenchyma sonography in movement disorders: state of the art. Ultrasound Med Biol 33:15–25

    Article  Google Scholar 

  11. Tao A, Chen G, Mao Z et al (2020) Essential tremor vs idiopathic Parkinson disease: utility of transcranial sonography. Medicine 99:e20028

    Article  Google Scholar 

  12. Godani M, Lanza G, Trevisan L et al (2021) An unusual gait disorder at the emergency department: role of the quantitative assessment of parenchymal transcranial Doppler sonography. Quant Imaging Med Surg 11:2195–2200

    Article  Google Scholar 

  13. Gerriets T, Stolz E, Modrau B, Fiss I, Seidel G, Kaps M (1999) Sonographic monitoring of midline shift in hemispheric infarctions. Neurology.

    Article  PubMed  Google Scholar 

  14. Gerriets T, Stolz E, König S, Babacan S, Fiss I, Jauss M, Kaps M (2001) Sonographic monitoring of midline shift in space-occupying stroke. Stroke 32:442–447

    Article  CAS  Google Scholar 

  15. Walter UKM, Wittstock M, Müller Ju, Benecke R, Wolters A (2011) Transcranial sonographic localization of deep brain stimulation electrodes is safe, reliable and predicts clinical outcome. Ultrasound Med Biol 37:1382–1391

    Article  Google Scholar 

  16. Schreiber SJ, Valdueza JM, Doepp F (2014) Transcranial color coded sonography: advanced approach using ultrasound fusion imaging. Int J Clin Neurosci Ment Health. 1(Suppl. 1):S16

    Article  Google Scholar 

  17. Walter U, Skoloudik D (2014) Transcranial sonography (TCS) of brain parenchyma in movement disorders: quality standards, diagnostic applications and novel technologies. Ultraschall Med 35:322–331

    Article  CAS  Google Scholar 

  18. Schreiber SJ, Sakas G, Kolev V et al (2015) Fusion imaging in neurosonology: clinician’s questions, technical potentials and applicability. Biomed Eng Lett 4:347–354

    Article  Google Scholar 

  19. Fleiss J (1971) Measuring normal scale agreement among many raters. Psychol Bull 76:378–382

    Article  Google Scholar 

  20. Behnke S, Becker G (2002) Sonographic imaging of the brain parenchyma. Eur J Ultrasound 16:73–80

    Article  Google Scholar 

  21. Walter U, Behnke S (2019) Transcranial sonography of brain parenchyma: established applications in adults. Klin Neurophysiol 50:73–82

    Article  Google Scholar 

  22. Maxeiner A, Nest AM, Stephan C et al (2020) Additive value of transrectal systematic ventral biopsies in combination with magnet resonance imaging/ultrasound fusion-guided biopsy in patients with 3 or more negative prostate biopsies. Urol Int 104:205–213

    Article  Google Scholar 

  23. Wu DF, He W, Lin S et al (2019) Using real-time fusion imaging constructed from contrast-enhanced ultrasonography and magnetic resonance imaging for high-grade glioma in neurosurgery. World Neurosurg 125:e98–e109

    Article  Google Scholar 

  24. Zedde M, Malferrari G, De Berti G et al (2012) Virtual navigator study: subset of preliminary data about cerebral venous circulation. Perspect Med 1:385–389

    Article  Google Scholar 

  25. Ghassaban K, He N, Sethi SK et al (2019) Regional high iron in the substantia nigra differentiates Parkinson’s disease patients from healthy controls. Front Aging Neurosci 11:106

    Article  CAS  Google Scholar 

  26. Walter U (2010) Transcranial sonography in brain disorders with trace metal accumulation. Int Rev Neurobiol 90:166–178

    Article  Google Scholar 

  27. Walter U, Skowronska M, Litwin T et al (2014) Lenticular nucleus hyperechogenicity in Wilson’s disease reflects local copper, but not iron accumulation. J Neural Transm 121:1273–1279

    Article  CAS  Google Scholar 

  28. Yu SY, Cao CJ, Zuo LJ et al (2018) Clinical features and dysfunctions of iron metabolism in Parkinson disease patients with hyper echogenicity in substantia nigra: a cross-sectional study. BMC Neurol 18:9

    Article  Google Scholar 

  29. Petersen M, Frey BM, Schlemm E et al (2020) Network localisation of white matter damage in cerebral small vessel disease. Sci Rep 10:9210

    Article  CAS  Google Scholar 

  30. Wardlaw JM, Valdes Hernandez MC, Munoz-Maniega S (2015) What are white matter hyperintensities made of? Relevance to vascular cognitive impairment. J Am Heart Assoc 4:001140

    Article  Google Scholar 

  31. Franz Fazekas RS, Scheltensc P (1998) Pathophysiologic mechanisms in the development of age related white matter changes of the brain. Dement Geriatr Cogn Disord 9(1):2–5

    Article  Google Scholar 

  32. Vinciguerra L, Lanza G, Puglisi V et al (2019) Transcranial Doppler ultrasound in vascular cognitive impairment-no dementia. PLoS ONE 14:e0216162

    Article  CAS  Google Scholar 

  33. Vagli C, Fisicaro F, Vinciguerra L et al (2020) Cerebral hemodynamic changes to transcranial Doppler in asymptomatic patients with fabry’s disease. Brain Sci 10:546

    Article  Google Scholar 

  34. Ciambra G, Arachi S, Protano C et al (2013) Accuracy of transcranial ultrasound in the detection of mild white matter lesions in newborns. Neuroradiol 26(3):284–289

    Article  CAS  Google Scholar 

  35. Horsch S, Skiold B, Hallberg B et al (2010) Cranial ultrasound and MRI at term age in extremely preterm infants. Arch Dis Child Fetal Neonatal Ed 95:F310-314

    Article  CAS  Google Scholar 

  36. Leijser LM, Srinivasan L, Rutherford MA et al (2009) Frequently encountered cranial ultrasound features in the white matter of preterm infants: correlation with MRI. Eur J Paediatr Neurol 13:317–326

    Article  Google Scholar 

  37. Skoloudik D, Bartova P, Maskova J et al (2016) Transcranial sonography of the insula: digitized image analysis of fusion images with magnetic resonance. Ultraschall Med 37:604–608

    Article  CAS  Google Scholar 

  38. Skoloudik D, Jelinkova M, Blahuta J et al (2014) Transcranial sonography of the substantia nigra: digital image analysis. AJNR Am J Neuroradiol 35:2273–2278

    Article  CAS  Google Scholar 

Download references


Not applicable.


This project was supported in part by a research grant of the Austrian Society of Neurology for the first author (18/2017).

Author information

Authors and Affiliations



CB and MRV were involved in study conception, data acquisition, drafting and reviewing the manuscript and design. StS participated in data acquisition and data analyzing. CB interpreted the data and prepared the manuscript. StS and MRV contributed to interpretation of the data and critically revised the manuscript for intellectual content. EDO and AN participated in image analysis and data collection. MB was responsible for MRI data acquisition and data interpretation. WS and GR were involved in data interpretation. All authors critically reviewed the final version of this manuscript. MRV is the guarantor of this work and, as such, had full access to all the data in the study. MRV and CB take responsibility for the integrity of the data and the accuracy of the data analysis The author read and approved the final manuscript

Authors' information

This project was awarded as “Best Young Investigator Study” in the 25th Conference of the European Society of Neurosonology and Cerebral Hemodynamics (Belgrade, 2021).

Corresponding author

Correspondence to Milan Rastislav Vosko.

Ethics declarations

Ethics approval and consent to participate

The study was approved by the local ethics committee (temporarily anonymized). All participants gave written informed consent.

Consent for publication

Not applicable.

Competing interests

There are no conflicts of interest with this project.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brunner, C., Schreiber, S.J., Bokemeyer, M. et al. Value of ultrasound fusion imaging in detecting vascular cerebral white matter pathology. Ultrasound J 14, 25 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: